Manna, S K
Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. [electronic resource]
- Journal of immunology (Baltimore, Md. : 1950) Feb 1999
- 2095-102 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 0022-1767
Subjects--Topical Terms: Aniline Compounds--antagonists & inhibitors Biological Transport--drug effects Cell Nucleus--drug effects Ceramides--antagonists & inhibitors Chloramphenicol O-Acetyltransferase--antagonists & inhibitors Crotonates DNA-Binding Proteins--antagonists & inhibitors Dithiothreitol--pharmacology Enzyme Activation--drug effects Gene Expression Regulation--drug effects Genes, MDR--drug effects Genes, Reporter--drug effects Host Cell Factor C1 Humans Hydrogen Peroxide--antagonists & inhibitors Hydroxybutyrates--antagonists & inhibitors I-kappa B Proteins Immunosuppressive Agents--antagonists & inhibitors Isoxazoles--antagonists & inhibitors Leflunomide Lipopolysaccharides--antagonists & inhibitors Lymphocyte Specific Protein Tyrosine Kinase p56(lck)--antagonists & inhibitors Mitogen-Activated Protein Kinase Kinases NF-KappaB Inhibitor alpha NF-kappa B--antagonists & inhibitors NF-kappa B p50 Subunit Nitriles Octamer Transcription Factor-1 Okadaic Acid--antagonists & inhibitors Protein Binding--drug effects Protein Kinase Inhibitors Protein Kinases--metabolism Tetradecanoylphorbol Acetate--antagonists & inhibitors Toluidines Transcription Factor AP-1--metabolism Transcription Factor RelA Transcription Factors--metabolism Tumor Cells, Cultured Tumor Necrosis Factor-alpha--antagonists & inhibitors